“…Our study detected that this bacterium was resistant to piperacillin, piperacillin/tazobactam, cefotaxime, imipenem, ciprofloxacin, moxifloxacin, and aztreonam, although it has been reported that the susceptibility to third‐generation cephalosporins and fluoroquinolones is variable (Al‐Halawani et al, ; Hsueh et al, ). Other studies reported that S. paucimobilis was resistant to amikacin, ceftazidime, and fluoroquinolones (Toh et al, ), resistant to cefoxitin and ceftazidime (Özdemir et al, ), and to cefotaxime and amikacin (Cheong et al, ). As there are no definitive guidelines for antimicrobial therapy for this bacterial infections, treatment is done with individualized antibiotic therapy according to the in vitro susceptibility profile of clinical isolates (Özdemir et al, ; Pratama et al, ; Toh et al, ).…”